Patents by Inventor Mary J. Janatpour

Mary J. Janatpour has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APCDD1 inhibitors for treating, diagnosing or detecting cancer
    Patent number: 8846005
    Abstract: The invention provides, inter alia, methods for methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with APCDD1 overexpression.
    Type: Grant
    Filed: March 14, 2008
    Date of Patent: September 30, 2014
    Assignee: Novartis AG
    Inventors: Mary J. Janatpour, Abdallah Fanidi, Shanling Shen, Karen Yu
  • APRIL ANTAGONISTS AND METHODS OF USE
    Publication number: 20120201823
    Abstract: The present invention provides antagonists of APRIL. In particular, the APRIL antagonists block unique receptor binding sited on APRIL, BCMA. TACI, and/or HSPG. Also provided are methods of use.
    Type: Application
    Filed: October 14, 2010
    Publication date: August 9, 2012
    Applicant: Schering Corporation
    Inventors: Mary J. Janatpour, Kathy L. Miller
  • Anti-REG4 Antibodies
    Publication number: 20110117080
    Abstract: Antibodies to human REG4 are provided, as well as uses thereof, e.g., in treatment of proliferative disorders. Also provided is a method of screening for an antibody that inhibits REG4 bioactivity.
    Type: Application
    Filed: November 12, 2010
    Publication date: May 19, 2011
    Applicant: Schering Corporation
    Inventors: Mary J. Janatpour, Kathryn E. Vanderlaag, Wei Wang
  • AMIGO-2-INHIBITORS FOR TREATING, DIAGNOSING OR DETECTING CANCER
    Publication number: 20110097261
    Abstract: The invention provides, inter alia, methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with AMIGO-2 overexpression.
    Type: Application
    Filed: July 19, 2007
    Publication date: April 28, 2011
    Inventor: Mary J. Janatpour
  • APCDD1 INHIBITORS FOR TREATING, DIAGNOSING OR DETECTING CANCER
    Publication number: 20100209342
    Abstract: The invention provides, inter alia, methods for methods for treating cancer, compositions for treating cancer, and methods and compositions for diagnosing and/or detecting cancer. In particular, the present invention provides compositions and methods for treating, diagnosing and detecting cancers associated with APCDD1 overexpression.
    Type: Application
    Filed: March 14, 2008
    Publication date: August 19, 2010
    Applicant: NOVARTIS AG
    Inventors: Mary J. Janatpour, Abdallah Fanidi, Shanling Shen, Karen Yu
  • Trefoil Factor 3 (Tff3) as a Target for Anti-Cancer Therapy
    Publication number: 20080233046
    Abstract: The present invention is directed to methods of treating and preventing cancer, such as cancer characterized by differential expression of trefoil factor 3 (TFF3). The methods include administering to a patient an agent that modulates TFF3 activity or expression. The present invention is further directed to reducing the physiological effects of TFF3 expression in cells, including inhibiting cell motility and resistance to apoptosis. Oligonucleotides and antibodies that can modulate expression or activity of TFF3 are also provided.
    Type: Application
    Filed: August 5, 2004
    Publication date: September 25, 2008
    Inventors: Mary J. Janatpour, Pablo Garcia, Christoph Reinhard